234 related articles for article (PubMed ID: 25369070)
1. MicroRNAs expression in triple negative vs non triple negative breast cancer in Tunisia: interaction with clinical outcome.
Medimegh I; Omrane I; Privat M; Uhrhummer N; Ayari H; Belaiba F; Benayed F; Benromdhan K; Mader S; Bignon IJ; Elgaaied AB
PLoS One; 2014; 9(11):e111877. PubMed ID: 25369070
[TBL] [Abstract][Full Text] [Related]
2. miR-10b, miR-26a, miR-146a And miR-153 Expression in Triple Negative Vs Non Triple Negative Breast Cancer: Potential Biomarkers.
Fkih M'hamed I; Privat M; Trimeche M; Penault-Llorca F; Bignon YJ; Kenani A
Pathol Oncol Res; 2017 Oct; 23(4):815-827. PubMed ID: 28101798
[TBL] [Abstract][Full Text] [Related]
3. Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers.
Fkih M'hamed I; Privat M; Ponelle F; Penault-Llorca F; Kenani A; Bignon YJ
Cell Oncol (Dordr); 2015 Dec; 38(6):433-42. PubMed ID: 26392359
[TBL] [Abstract][Full Text] [Related]
4. Decreased expression of key tumour suppressor microRNAs is associated with lymph node metastases in triple negative breast cancer.
Avery-Kiejda KA; Braye SG; Mathe A; Forbes JF; Scott RJ
BMC Cancer; 2014 Jan; 14():51. PubMed ID: 24479446
[TBL] [Abstract][Full Text] [Related]
5. MiR-148a functions to suppress metastasis and serves as a prognostic indicator in triple-negative breast cancer.
Xu X; Zhang Y; Jasper J; Lykken E; Alexander PB; Markowitz GJ; McDonnell DP; Li QJ; Wang XF
Oncotarget; 2016 Apr; 7(15):20381-94. PubMed ID: 26967387
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA expression analysis in triple-negative (ER, PR and Her2/neu) breast cancer.
Radojicic J; Zaravinos A; Vrekoussis T; Kafousi M; Spandidos DA; Stathopoulos EN
Cell Cycle; 2011 Feb; 10(3):507-17. PubMed ID: 21270527
[TBL] [Abstract][Full Text] [Related]
7. MiR-128 regulation of glucose metabolism and cell proliferation in triple-negative breast cancer.
Xiao M; Lou C; Xiao H; Yang Y; Cai X; Li C; Jia S; Huang Y
Br J Surg; 2018 Jan; 105(1):75-85. PubMed ID: 29116653
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24.
Li Z; Meng Q; Pan A; Wu X; Cui J; Wang Y; Li L
Oncotarget; 2017 Mar; 8(12):19455-19466. PubMed ID: 28038450
[TBL] [Abstract][Full Text] [Related]
9. Repression of miR-146a in predicting poor treatment outcome in triple-negative breast cancer.
Panoutsopoulou K; Liu Y; Avgeris M; Dreyer T; Dorn J; Magdolen V; Scorilas A
Clin Biochem; 2023 Apr; 114():43-51. PubMed ID: 36502883
[TBL] [Abstract][Full Text] [Related]
10. Secreted breast tumor interstitial fluid microRNAs and their target genes are associated with triple-negative breast cancer, tumor grade, and immune infiltration.
Terkelsen T; Russo F; Gromov P; Haakensen VD; Brunak S; Gromova I; Krogh A; Papaleo E
Breast Cancer Res; 2020 Jun; 22(1):73. PubMed ID: 32605588
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs discriminate familial from sporadic non-BRCA1/2 breast carcinoma arising in patients ≤35 years.
Bastos EP; Brentani H; Pasini FS; Silva AR; Torres CH; Puga RD; Ribeiro Olivieri EH; Piovezani AR; Pereira CA; Machado-Lima A; Carraro DM; Brentani MM
PLoS One; 2014; 9(7):e101656. PubMed ID: 25006670
[TBL] [Abstract][Full Text] [Related]
12. Expression and polymorphism of micro-RNA according to body mass index and breast cancer presentation in Tunisian patients.
Belaiba F; Medimegh I; Ammar M; Jemni F; Mezlini A; Romdhane KB; Cherni L; Benammar Elgaaïed A
J Leukoc Biol; 2019 Feb; 105(2):317-327. PubMed ID: 30303554
[TBL] [Abstract][Full Text] [Related]
13. Identification of Specific miRNA Signature in Paired Sera and Tissue Samples of Indian Women with Triple Negative Breast Cancer.
Thakur S; Grover RK; Gupta S; Yadav AK; Das BC
PLoS One; 2016; 11(7):e0158946. PubMed ID: 27404381
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
[TBL] [Abstract][Full Text] [Related]
15. miR-146a and miR-638 in BRCA1-deficient triple negative breast cancer tumors, as potential biomarkers for improved overall survival.
Zavala V; Pérez-Moreno E; Tapia T; Camus M; Carvallo P
Cancer Biomark; 2016; 16(1):99-107. PubMed ID: 26835710
[TBL] [Abstract][Full Text] [Related]
16. A subgroup of microRNAs defines PTEN-deficient, triple-negative breast cancer patients with poorest prognosis and alterations in RB1, MYC, and Wnt signaling.
Wang DY; Gendoo DMA; Ben-David Y; Woodgett JR; Zacksenhaus E
Breast Cancer Res; 2019 Jan; 21(1):18. PubMed ID: 30704524
[TBL] [Abstract][Full Text] [Related]
17. miR-629-3p may serve as a novel biomarker and potential therapeutic target for lung metastases of triple-negative breast cancer.
Wang J; Song C; Tang H; Zhang C; Tang J; Li X; Chen B; Xie X
Breast Cancer Res; 2017 Jun; 19(1):72. PubMed ID: 28629464
[TBL] [Abstract][Full Text] [Related]
18. A prognostic model of triple-negative breast cancer based on miR-27b-3p and node status.
Shen S; Sun Q; Liang Z; Cui X; Ren X; Chen H; Zhang X; Zhou Y
PLoS One; 2014; 9(6):e100664. PubMed ID: 24945253
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of MiR-146a-5p Upregulates lncRNA HOTAIR in Triple-Negative Breast Cancer Cells and Predicts Poor Prognosis.
Liang H; Huang W; Wang Y; Ding L; Zeng L
Technol Cancer Res Treat; 2019; 18():1533033819882949. PubMed ID: 31672084
[TBL] [Abstract][Full Text] [Related]
20. miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer.
Li HY; Liang JL; Kuo YL; Lee HH; Calkins MJ; Chang HT; Lin FC; Chen YC; Hsu TI; Hsiao M; Ger LP; Lu PJ
Breast Cancer Res; 2017 Dec; 19(1):133. PubMed ID: 29258605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
